Methods for managing variation in clinical drug names.
Year: 2010
Type: conference-paper
Abstract: OBJECTIVES: To develop normalization methods for managing the variation in clinical drug names. METHODS: Manual examination of drug names from RxNorm and local variants collected from formularies led to the identification of three types of drug-specific normalization rules: expansion of abbreviations (e.g., tab to tablet);reformatting of specific elements (e.g., space between number and unit); and removal of salt variants (e.g., succinate from metoprolol succinate). RESULTS: After drug-specific normalization, recall of 3397 previously non-matching names from formularies reaches 45% overall (70% of some subsets), compared to 10-20% after generic normalization. Ambiguity has not increased significantly in the RxNorm dataset. CONCLUSIONS: A limited number of drug-specific normalization operations provide significant improvement over general language normalization.
Source: PubMed
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W155235004
